JADA ALSTON: Open Payments
NPI 1427692375 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,590 in 147 payments from 21 companies in 2025. Trend: 2023 $3,396 · 2024 $3,697 · 2025 $4,590
Food & beverage: $3,521Travel & lodging: $1,069
| Company | Payments | Amount |
|---|---|---|
| Brainsway USA INC | 1 | $1,069 |
| Neurocrine BioSciences, Inc. | 17 | $476 |
| Otsuka America Pharmaceutical, Inc. | 15 | $375 |
| ABBVIE INC. | 26 | $373 |
| Vanda Pharmaceuticals Inc. | 12 | $356 |
| Janssen Pharmaceuticals, Inc | 10 | $307 |
| Teva Pharmaceuticals USA, Inc. | 16 | $283 |
| Alkermes, Inc. | 7 | $259 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $242 |
| E.R. Squibb & Sons, L.L.C. | 5 | $141 |
Products named: Deep TMS System, INGREZZA, VRAYLAR, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, HETLIOZ, FANAPT.
Industry payments across CA — which companies pay providers there.
